114 related articles for article (PubMed ID: 9929937)
41. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer.
Teuffel O; Amir E; Alibhai SM; Beyene J; Sung L
Pediatrics; 2011 Feb; 127(2):e279-86. PubMed ID: 21220399
[TBL] [Abstract][Full Text] [Related]
42. [Epidemiology of febrile neutropenia in adult patients with hematologic neoplasms in a period of 26 months in Hospital Pablo Tobón Uribe, Colombia].
Madrid C; Díaz L; Combariza J; Gálvez K; Olaya V; Ramírez I; Donado J
Rev Chilena Infectol; 2013 Apr; 30(2):195-201. PubMed ID: 23677158
[TBL] [Abstract][Full Text] [Related]
43. [Strategies of treatment for febrile neutropenia].
Terui Y
Gan To Kagaku Ryoho; 2013 Jun; 40(6):688-92. PubMed ID: 23863644
[TBL] [Abstract][Full Text] [Related]
44. Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana.
Vanderpuye V; Yarney J; Beecham K
West Afr J Med; 2010; 29(5):303-8. PubMed ID: 21089015
[TBL] [Abstract][Full Text] [Related]
45. Management of fever in patients with cancer and treatment-induced neutropenia.
Pizzo PA
N Engl J Med; 1993 May; 328(18):1323-32. PubMed ID: 8469254
[No Abstract] [Full Text] [Related]
46. Clinical and economic considerations of empirical antibacterial therapy of febrile neutropenia in cancer.
Dranitsaris G
Pharmacoeconomics; 1999 Oct; 16(4):343-53. PubMed ID: 10623363
[TBL] [Abstract][Full Text] [Related]
47. Utility of multiplex PCR in detecting the causative pathogens for pediatric febrile neutropenia.
Mitsuda Y; Takeshima Y; Mori T; Yanai T; Hayakawa A; Matsuo M
Kobe J Med Sci; 2011 Aug; 57(2):E32-7. PubMed ID: 22926071
[TBL] [Abstract][Full Text] [Related]
48. [Current clinical practice in the treatment of febrile neutropenia (FN)].
Takei N; Komatsu T
Jpn J Antibiot; 2011 Oct; 64(5):293-310. PubMed ID: 22428213
[TBL] [Abstract][Full Text] [Related]
49. Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies?
Agrawal AK; Saini N; Gildengorin G; Feusner JH
Pediatr Blood Cancer; 2011 Oct; 57(4):620-4. PubMed ID: 21265012
[TBL] [Abstract][Full Text] [Related]
50. Clinical impact of cycling the administration of antibiotics for febrile neutropenia in Japanese patients with hematological malignancy.
Hashino S; Morita L; Kanamori H; Takahata M; Onozawa M; Nakagawa M; Kawamura T; Fujisawa F; Kahata K; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Asaka M
Eur J Clin Microbiol Infect Dis; 2012 Feb; 31(2):173-8. PubMed ID: 21594713
[TBL] [Abstract][Full Text] [Related]
51. Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore.
Jin J; Lee YM; Ding Y; Koh LP; Lim SE; Lim R; Tambyah PA; Hsu LY
Ann Acad Med Singap; 2010 Jun; 39(6):453-9. PubMed ID: 20625621
[TBL] [Abstract][Full Text] [Related]
52. Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors.
Carmona-Bayonas A; Jiménez-Fonseca P; Virizuela J; Antonio M; Font C; Biosca M; Ramchandani A; Martinez-Garcia J; Hernando J; Espinosa J; de Castro EM; Ghanem I; Beato C; Blasco A; Garrido M; Mondéjar R; Arcusa MÁ; Aragón I; Manzano A; Sevillano E; Castañón E; Ayala F;
Clin Transl Oncol; 2017 Mar; 19(3):386-395. PubMed ID: 27525978
[TBL] [Abstract][Full Text] [Related]
53. Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines.
Naeem D; Alshamrani MA; Aseeri MA; Khan MA
Pharmacy (Basel); 2018 Aug; 6(3):. PubMed ID: 30103459
[No Abstract] [Full Text] [Related]
54. Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients.
Teuffel O; Cheng S; Ethier MC; Diorio C; Martino J; Mayo C; Wing R; Sung L; Alibhai SM
Support Care Cancer; 2012 Nov; 20(11):2755-64. PubMed ID: 22350594
[TBL] [Abstract][Full Text] [Related]
55. Fever, infection and cancer patient.
Umsawasdi T
J Med Assoc Thai; 1975 Apr; 58(4):183-5. PubMed ID: 1133502
[No Abstract] [Full Text] [Related]
56. PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study.
Morgan JE; Phillips B
BMJ Paediatr Open; 2022 Mar; 6(1):. PubMed ID: 36053620
[TBL] [Abstract][Full Text] [Related]
57. Management of febrile neutropenia in pediatric oncology across Queensland, Australia: a retrospective review on variations between locations.
Cox A; Bradford N
J Pediatr Oncol Nurs; 2014; 31(1):28-33. PubMed ID: 24378817
[TBL] [Abstract][Full Text] [Related]
58. Symptom to door interval in febrile neutropenia: perspective in India.
Oberoi S; Trehan A; Marwaha RK; Bansal D
Support Care Cancer; 2013 May; 21(5):1321-7. PubMed ID: 23242386
[TBL] [Abstract][Full Text] [Related]
59. Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients.
Carmona-Bayonas A; Gómez J; González-Billalabeitia E; Canteras M; Navarrete A; Gonzálvez ML; Vicente V; Ayala de la Peña F
Br J Cancer; 2011 Aug; 105(5):612-7. PubMed ID: 21811253
[TBL] [Abstract][Full Text] [Related]
60. Microbiology of febrile neutropenia: European data on incidence and resistance.
Picazo JJ
Int J Hematol; 1998 Oct; 68 Suppl 1():S35-8. PubMed ID: 9838743
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
